Navigation Links
Leading NGOs call for international action to combat epidemic of noncommunicable diseases
Date:5/19/2009

GENEVA, Switzerland, May 19, 2009 The International Diabetes Federation (IDF), International Union Against Cancer (UICC) and World Heart Federation (WHF) today issued a joint statement that calls on the international community to address urgently the epidemic of non-communicable diseases (NCDs), responsible for 35 million deaths a year. The statement demands a substantial increase in funding for NCDs and greater availability of essential medicines, among other urgent responses, in a way to accelerate achievement of the health Millennium Development Goals.

Public health experts are concerned about the impact of the global economic crisis and warn that the emerging epidemic of NCDs is threatening to overwhelm healthcare systems worldwide unless action is taken. Cardiovascular disease, diabetes, cancer and chronic respiratory diseases cause 60% of all deaths worldwide, with four in every five of these deaths occurring in low- and middle-income countries. NCDs are an under-appreciated cause of poverty and now present a serious barrier to economic development. They are estimated to reduce gross domestic product (GDP) by up to 5% in many low- and middle-income countries, dealing a double blow to fragile economies struggling in the global recession.

Professor Pekka Puska, President of the World Heart Federation states: "We can no longer ignore the burden that cardiovascular disease, together with the other NCDs including diabetes, cancer and chronic respiratory diseases, is placing on countries that are least equipped to deal with them. We urgently call on the international community to ensure that the funding models applied to infectious diseases, such as HIV/AIDS, TB and malaria are expanded to stop the spiralling death rates from NCDs before the most vulnerable are pushed further into the poverty trap."

NCDs impact on the world

IDF, WHF and UICC are united by their concern with the consequences of physical inactivity, tobacc
'/>"/>

Contact: Kerrita McClaughlyn
media@idf.org
32-487-530-625
International Diabetes Federation
Source:Eurekalert

4

GOOD

Page: 1 2 3 4

Related medicine news :

1. Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records
2. Cynosure Enhances Industry-Leading Smartlipo Laser Lipolysis Workstation with Increased Energy and Intelligent Temperature Sensing
3. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
4. Leading Italian Pharmaceutical Group Deploys TrackWise(R) Solution to Improve Quality Processes
5. iCardiac's Highly Automated QT(sm) Technology Cross-Validated Against Results from Five Leading ECG Core Laboratories
6. MedAptus Charge Capture Technology Deployed at Leading Manhattan Cardiovascular Practice
7. Video: Research in Womens Cancers Leading the Personalized Medicine Revolution
8. Video: New Survey Finds 97 Percent of Women Understand Weight Increases Heart Disease Risk - The Leading Cause of Female Death in the United States - Yet 55 Percent Remain Overweight
9. Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications
10. Aging Advocate Named President of Marylands Leading Long-Term Care Association
11. Barriers to Health Care, Prescription Choice Hurt Patients, Leading Doctor Says

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...Nov.27/PRNewswire-USNewswire/--Consideredahighlyri...solidorgantransplantationisnowalife-savingmainstre...atheredattheWinspearOperaHouseinDallasonNov.11.Lea...celebratethe25thanniversaryofBaylorRegionalTranspl...nsplantintheUnitedStates. ,, Itwas25yearsagotha...
(Date:11/27/2009)... XenaCare Holdings has announced that it...undation, one of the largest nonprofit organizatio...th education. , Delray Be...ings, Inc. (OTCBB: XCHO), a company specializing i...r healthcare products, has announced today that is...
(Date:11/27/2009)... Multi-purpose bilingual coloring books ...se by the business community to educate - inform p... from Safety issues to Dinosuars to ABC,S and a ho...nt Louis, MO (PRWEB) November 27, 2009 -- Today&rs... toys to keep them busy any hour of the day, but o...
(Date:11/26/2009)...5 years, the number of Americans living with diabe...on in 2009 to 44.1 million in 2034. Over the same ...ising from $113 billion to $336 billion, even with...hers based at the University of Chicago report in ...ber of those with diabetes covered by Medicare wil...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Ce...Dallas , is one of a growing number of physicians ...king sites to connect with individuals who are int... morbid obesity. Dr. Kim is utilizing Facebook to ...t his practice with the community. , ...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...IS, July 1 Uroplasty, Inc. (Amex:,UPI), a medical...rkets,innovative proprietary products for the trea... it was added to the Russell Microcap(R) Index whe... which remains in place for one,year, means automa...
...LIS, July 1 CoLucid Pharmaceuticals, Inc., an,inn...s for central nervous,system disorders, announced ...vestor Care Capital led the round, which included ...r develop a,unique migraine compound, COL-144, and...
... New research shows that a majori... pay higher taxes to fund increased education faci...d consumer attitudes to the recruitment of nurses ...are survey are concerned about the on-going effect...
...ELPHIA In the first study of its kind, researcher...Medicine,s Ross Koppel, Ph.D. studied how hospital...ches the right patient with the right dose of the ...tion administration errors, is flawed, and can inc...
...follow-up to research showing that psilocybin, a s... substantial spiritual effects, a Johns Hopkins te... last more than a year. , Writing in the Journa... Hopkins study published in 2006, continued to say...
...E, N.J., June 30 Janssen, Division,of Ortho-McNei... has,launched an authorized generic version of RIS...icals, L.L.C., Patriot is a subsidiary of McNeil-...RISPERDAL, which was first approved by the FDA in ...
Other Medicine News:Health News:Uroplasty Joins the Russell Microcap Index 2Health News:Uroplasty Joins the Russell Microcap Index 3Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 2Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 3Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 4Health News:Education More Important Than Immigration to Solve Nursing Shortage, Research Shows 2Health News:Education More Important Than Immigration to Solve Nursing Shortage, Research Shows 3Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 2Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 3Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 4Health News:Spiritual effects of hallucinogens persist, Johns Hopkins researchers report 2Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 2Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 3Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 4
(Date:11/25/2009)...DGE, N.J., Nov. 25 Regado Bioscien...ent of antithrombotic aptamers with active control...President, will be presenting at the Piper Jaffray...k Palace Hotel in New York City. Dr. Mazzo,s pres... December 1 and will include an overview of the Co...
(Date:11/25/2009)...ORK, Nov. 25 Reportlinker.com anno...le in its catalogue: ,, Mammography Equipment....reportlinker.com/p0164330/Mammography-Equipment--...cidence of breast cancer in industrialized as well...encing growth in the mammography market. Globally,...
(Date:11/25/2009)...AM, Mass., Nov. 25 According to Mi...y on medical technology market intelligence, the n...ices will continue to see rapid growth over the ne.... MRG,s US Markets for Trauma Devices 2010 rep...mic over the next five years, with competitors int...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 1This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 2This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 3PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach 53020 1PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach 53020 2SAFC Biosciences 28R 29 Defines Hydrolysate Components That Enhance Chinese Hamster Ovary 28CHO 29 Cell Line Protein Production 13241 1SAFC Biosciences 28R 29 Defines Hydrolysate Components That Enhance Chinese Hamster Ovary 28CHO 29 Cell Line Protein Production 13241 2SAFC Biosciences 28R 29 Defines Hydrolysate Components That Enhance Chinese Hamster Ovary 28CHO 29 Cell Line Protein Production 13241 3SAFC Biosciences 28R 29 Defines Hydrolysate Components That Enhance Chinese Hamster Ovary 28CHO 29 Cell Line Protein Production 13241 4
...IOPHARM Oncology,Inc. (NASDAQ: ZIOP), announced t...nnual International Myeloma Workshop being,held in...highlights,important advances made in the biology ...senting darinaparsin (ZIO-101) gene,expression pro...hanism of action as well as interim Phase II data ...
...CADE, lenalidomide,and dexamethasone , ,KOS, Greec...armaceuticals, Inc. (Nasdaq: MLNM) today reported ...trials of VELCADE based,therapies that showed cons...mplete response(1) (CR) rates in newly diagnosed,m...sented at the,prestigious 11th International Myelo...
Other Medicine Technology:ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 2ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 3ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 2Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 3Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 6Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 7Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 8
Sealing Mat for 384-well PCR plate
...pha unit, these new pads may be used in applicatio...essive runs may be sealed with the same pad. The M...te from sticking to the block and lid, and Microse...rformance, which means you can use as little as 50...
...pha unit, these new pads may be used in applicatio...essive runs may be sealed with the same pad. The...late from sticking to the block and lid, and Micro...performance, which means you can use as little as ...
Microseal 'M' mats
Medicine Products: